Skip to main content
SpringerLink
Log in

Classification of benzodiazepine hypnotics in humans based on receptor occupancy theory

  • Published:
Journal of Pharmacokinetics and Biopharmaceutics Aims and scope Submit manuscript

Abstract

Benzodiazepine (BZP) hypnotics are now classified into four groups according to their plasma elimination rates: ultrashort-, short-, intermediate-, and long-acting drugs. Since the specific binding affinities for the BZP receptor vary widely among the BZPs and their active metabolites, it may be more reasonable to correlate their pharmacological activities with the BZP receptor occupancy rather than with their plasma concentrations. The time courses of total plasma concentrations of BZPs and their active metabolites after a single oral administration were obtained from the literature, and their unbound concentrations (Cu)were calculated from the reported values of their plasma unbound fractions. The data of the receptor binding affinities of the BZPs, reported as dissociation constants (Kd)determined by in vitrobinding experiments, were also obtained from the literature. Using these values, the time courses of receptor occupancies [Cu/(Kd + Cu) ×100%] were calculated for the various BZPs. A mutual competitive inhibition was considered in the case of the drugs that had active metabolites. Although plasma total and unbound concentration time profiles of the BZPs showed a wide variation, similar patterns were obtained for the time courses of the receptor occupancy among the BZPs in each group, indicating that the BZP hypnotics can be classified more conveniently based on receptor occupancy theory.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. M. Murasaki. The hypnotics [in Japanese],J. Ther. 72:1333–1342 (1990).

    Google Scholar 

  2. H. Ishizuka, Y. Sawada, K. Ito, Y. Sugiyama, H. Suzuki, T. Iga, and M. Hanano. Nonlinear relationship between benzodiazepine receptor occupancy and glucose metabolic response in the conscious mouse brainin vivo.J. Pharmacol. Exp. Ther. 251:362–367 (1989).

    CAS  PubMed  Google Scholar 

  3. Y. Sawada, K. Ito, Y. Sugiyama, M. Hanano, and T. Iga. Kinetic evaluation of pharmacological effects based on allosteric coupling of benzodiazepine/γ-aminobutyric acidA receptor in the brain.Chem. Pharm. Bull. 39:1820–1827 (1991).

    Article  CAS  PubMed  Google Scholar 

  4. K. Ito, Y. Sawada, Y. Sugiyama, M. Hanano, and T. Iga. Kinetic evaluation for measurement ofin vivo receptor occupancy by psychotropic drug in brain: Implication for human studies.Chem. Pharm. Bull. 39:1813–1819 (1991).

    Article  CAS  PubMed  Google Scholar 

  5. P. D. Garzone and P. D. Kroboth. Pharmacokinetics of the newer benzodiazepines.Clin. Pharmacokin. 16:337–364 (1989).

    Article  CAS  Google Scholar 

  6. W. Sieghart and A. Schuster. Affinity of various ligands for benzodiazepine receptors in rat cerebellum and hippocampus.Biochem. Pharmacol. 33:4033–4038 (1984).

    Article  CAS  PubMed  Google Scholar 

  7. F. S. Eberts, Jr., Y. Philopoulos, L. M. Reineke, and R. W. Vliek. Triazolam disposition.Clin. Pharmacol. Ther. 29:81–93 (1981).

    Article  CAS  PubMed  Google Scholar 

  8. L. J. Moschitto and D. J. Greenblatt. Concentration-independent plasma protein binding of benzodiazepines.J. Pharm. Pharmacol. 35:179–180 (1983).

    Article  CAS  PubMed  Google Scholar 

  9. R. Jochemsen, J. G. J. Wesselman, C. J. van Boxtel, J. Hermans, and D. D. Breimer. Comparative pharmacokinetics of brotizolam and triazolam in healthy subjects.Br. J. Clin. Pharmacol. 16:2918–2978 (1983).

    Google Scholar 

  10. H. Mohler and J. G. Richards. Benzodiazepine receptors in the central nervous system. In E. Costa (ed.),The Benzodiazepines: From Molecular Biology to Clinical Practice, Raven, New York, 1983, pp. 93–116.

    Google Scholar 

  11. P. Danneberg, K. Boke-Kuhn, W. D. Bechtel, and E. Lehr. Pharmacological action of some known and possible metabolites of brotizolam.Arzneim. Forsch. 36:587–591 (1986).

    CAS  Google Scholar 

  12. T. Yoshida, Y. Oiwa, S. Kobayashi, R. Matsumura, and H. Kohei. Absorption, distribution and excretion of14C-brotizolam.Japan Pharmacol Ther. 13:3333–3344 (1985).

    CAS  Google Scholar 

  13. R. G. Dorow, J. Seidler, and H. H. Schneider. A radioreceptor assay to study the affinity of benzodiazepines and their receptor binding activity in human plasma including their active metabolites.Br. J. Clin. Pharmacol. 13:561–565 (1982).

    CAS  PubMed Central  PubMed  Google Scholar 

  14. K. Kuriyama and S. Tomono. Significance of the enhancement of GABA receptor binding with low affinity in the assessment of central effects of benzodiazepine derivatives: Analysis using a 1H-1,2,4-triazolyl benzophenone derivative (450191-S).Neurochem. Int. 9:91–98 (1986).

    Article  CAS  PubMed  Google Scholar 

  15. H. Yamada, T. Oguma, K. Sugeno, T. Yamaguchi, M. Kono, G. Kominami, I. Namura, S. Iijima, J. Azuma, and K. Sakamoto. Pharmacokinetics of a novel hypnotic, 450191-S in healthy volunteers.Japan J. Clin. Pharmacol. Ther. 19:607–624 (1988).

    Article  CAS  Google Scholar 

  16. W. Sieghart, A. Eichinger, P. Riederer, and K. Jellinger. Comparison of benzodiazepine receptor binding in membranes from human or rat brain.Neuropharmacology 24:751–759 (1985).

    Article  CAS  PubMed  Google Scholar 

  17. L. Aaltonen, R. Lammintausta, L. Kangas, and L. Nieminen. Benzodiazepine binding to receptors in rat brain synaptosomal membranes: Characterization of benzodiazepines and their metabolites using3H-flunitrazepam. Presented at XVI Scandinavian Congress of Physiology and Pharmacology, Oulu, 1979, p. 68.

  18. T. Okada. The benzodiazepine receptor [in Japanese].Japan J. Neuropsychopharmacol. 2:5–16 (1980).

    Google Scholar 

  19. H. G. Boxenbaum, H. N. Posmanter, T. Macasieb, K. A. Geitner, R. E. Weinfeld, J. D. Moore, A. Darragh, D. A. O'Kelly, L. Weissman, and S. A. Kaplan. Pharmacokinetics of flunitrazepam following single-and multiple-dose oral administration to healthy human subjects.J. Pharmacokin. Biopharm. 6:283–293 (1978).

    Article  CAS  Google Scholar 

  20. P. A. Borea and A. Bonora. Brain receptor binding and lipophilic character of benzodiaz-epines.Biochem. Pharmacol. 32:603–607 (1983).

    Article  CAS  PubMed  Google Scholar 

  21. G. H. Loew, J. R. Nienow and M. Poulsen. Theoretical structure-activity studies of benzodiazepine analogues: Requirements for receptor affinity and activity.Mol. Pharma-col. 26:19–34 (1984).

    CAS  Google Scholar 

  22. L. Kangas and D. D. Breimer. Clinical pharmacokinetics of nitrazepam.Clin. Pharmaco-kin. 6:346–366 (1981).

    Article  CAS  Google Scholar 

  23. H. Boxenbaum. Comparative pharmacokinetics of benzodiazepines in dog and man.J. Pharmacokin. Biopharm. 10:411–426 (1982).

    Article  CAS  Google Scholar 

  24. L. G. Miller, D. J. Greenblatt, D. R. Abernethy, H. Friedman, M. D. Luu, S. M. Paul, and R. I. Shader. Kinetics, brain uptake, and receptor binding characteristics of flurazepam and its metabolites.Psychopharmacology 94:386–391 (1988).

    Article  CAS  PubMed  Google Scholar 

  25. M. Chung, J. M. Hibert, R. P. Gural, E. Radwanski, S. Symchowicz, and N. Zampaglione. Multiple-dose quazepam kinetics.Clin. Pharmacol. Ther. 35:520–524 (1984).

    Article  CAS  PubMed  Google Scholar 

  26. L. E. Gustavson and P. J. Carrigan. The clinical pharmacokinetics of single doses of estazolam.Am. J. Med. 88(Suppl 3A): 2S-5S (1990).

    Article  CAS  PubMed  Google Scholar 

  27. H. Fukazawa, H. Ichishita, M. Honda, and H. Shimizu. Pharmacokinetic studies of flunitrazepam in healthy male Japanese subjects.Rinsho-Yakuri 9:251–265 (1978).

    Article  CAS  Google Scholar 

  28. L. Kangas, E. Lisalo, J. Kanto, V. Lehtinen, S. Pynnonen, I. Ruikka, J. Salminen, M. Sillanpaa, and E. Syvalahti. Human pharmacokinetics of nitrazepam: Effect of age and diseases.Eur. J. Clin. Pharmacol. 15:163–170 (1979).

    Article  CAS  PubMed  Google Scholar 

  29. J. M. Hilbert, M. Chung, G. Maier, R. Gural, S. Symchowicz, and N. Zampaglione. Effect of sleep on quazepam kinetics.Clin. Pharmacol. Ther. 36:99–104 (1984).

    Article  CAS  PubMed  Google Scholar 

  30. U. Quast, H. Mahlmann, and K. D. Vollmer. Temperature dependence of the benzodiaz-epine-receptor interaction.Mol. Pharmacol. 22:20–25 (1982).

    CAS  PubMed  Google Scholar 

  31. R. K. Dubey, C. B. McAllister, M. Inoue, and G. R. Wilkinson. Plasma binding and transport of diazepam across the blood-brain barrier: No evidence forin vivo enhanced dissociation.J. Clin. Invest. 84:1155–1159 (1989).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  32. W. E. Haefely. Pharmacology of the allosteric modulation of GABAA receptors by benzodiazepine receptor ligands. In E. A. Barnard and E. Costa (eds.),Allosteric Modulation of Amino Acid Receptors: Therapeutic Implications, Raven Press, New York, 1989, pp. 47–69.

    Google Scholar 

  33. D. Farb, L. A. Borden, C. Y. Chan, C. M. Czajkowski, T. T. Gibbs, and G. D. Schiller. Modulation of neuronal function through benzodiazepine receptors: Biochemical and electrophysiological studies of neurons in primary monolayer cell culture.Ann. N. Y. Acad. Sci. 435:1–31 (1984).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacy, The University of Tokyo Hospital, Faculty of Medicine, The University of Tokyo, Bunkyo-ku, 113, Tokyo, Japan

    Kiyomi Ito, Yasuhiko Yamada, Kouichi Nakamura, Yasufumi Sawada & Tatsuji Iga

Authors
  1. Kiyomi Ito
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yasuhiko Yamada
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kouichi Nakamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yasufumi Sawada
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tatsuji Iga
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This study was supported in part by a Grant-in-Aid for Scientific Research provided by the Ministry of Education, Science and Culture of Japan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ito, K., Yamada, Y., Nakamura, K. et al. Classification of benzodiazepine hypnotics in humans based on receptor occupancy theory. Journal of Pharmacokinetics and Biopharmaceutics 21, 31–41 (1993). https://doi.org/10.1007/BF01061774

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01061774

Key words

Search

Navigation